Gemcitabine-induced apoptosis in a drug-resistant mouse leukemia L1210 cell line that does not express p53.
Cory
Ann H
AH
Department of Biochemistry and Molecular Biology, Brody School of Medicine, East Carolina University, Greenville, NC 27858-4354, USA.
Cory
Joseph G
JG
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D002453:Cell Cycle / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D045744:Cell Line, Tumor; D003839:Deoxyadenosines / Q000494:pharmacology; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm; D005419:Flavonoids / Q000494:pharmacology; D007939:Leukemia L1210 / Q000473:pathology*; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D010880:Piperidines / Q000494:pharmacology; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003839:Deoxyadenosines; D005419:Flavonoids; D010880:Piperidines; D016159:Tumor Suppressor Protein p53; D003841:Deoxycytidine; C077990:alvocidib; D008727:Methotrexate; D000093542:Gemcitabine